DR BELLS POMADE (Genomma lab USA Inc.)
Welcome to the PulseAid listing for the DR BELLS POMADE drug offered from Genomma lab USA Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genomma lab USA Inc. |
NON-PROPRIETARY NAME: | Triple Antibiotic Plus Pain Relief |
SUBSTANCE NAME: | BACITRACIN ZINC; POLYMYXIN B SULFATE; NEOMYCIN SULFATE; PRAMOXINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2012-05-16 |
END MARKETING DATE: | 0000-00-00 |
DR BELLS POMADE HUMAN OTC DRUG Details:
Item Description | DR BELLS POMADE from Genomma lab USA Inc. |
LABELER NAME: | Genomma lab USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500; 10000; 3.5; 10([USP’U]/g; [USP’U]/g; mg/g; mg/g) |
START MARKETING DATE: | 2012-05-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50066-161_671d14d7-d8b7-4999-94ac-727cb237b564 |
PRODUCT NDC: | 50066-161 |
APPLICATION NUMBER: | part333B |
Other BACITRACIN ZINC; POLYMYXIN B SULFATE; NEOMYCIN SULFATE; PRAMOXINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: